Latest filing published 09 Feb 2015 for Nuveen Real Estate Income Fund, €3,152.
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -72.0%Entry US$15.83 · Close at T+365 US$4.44
- -81.3%Entry US$19.25 · Close at T+365 US$3.60
- -47.0%Entry US$22.40 · Close at T+365 US$11.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Cedric H. Antosiewicz: trading record in brief
Cedric H. Antosiewicz discloses dealings in Nuveen Real Estate Income Fund to SEC (Form 4). The record holds 16 filings, for trades running from 17 September 2007 to 6 February 2015.
The open-market side counts 3 purchases for €67k alongside 13 sales for €73k. Taken together, the sales exceed the purchases by €5,964. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2015 to date brings no purchases and 1 sale.
A typical purchase (the median) is worth €12k. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -13.1%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 9 February 2015: an open-market sale of €3,152, in Nuveen Real Estate Income Fund. The latest purchase dates back some time: it was published 6,900 days ago, on 18 December 2007. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Cedric H. Antosiewicz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 303.87 shares@ US$11.90Common StockSEC:0001225208-15-003228:0
- 90 shares@ US$9.59Common StockSEC:0001225208-14-000664:0
- 200 shares@ US$9.58Common StockSEC:0001225208-14-000664:1
- 200 shares@ US$9.54Common StockSEC:0001225208-14-000664:2
- 400 shares@ US$9.58Common StockSEC:0001225208-14-000664:4
- 400 shares@ US$9.57Common StockSEC:0001225208-14-000664:5
- 650 shares@ US$9.58Common StockSEC:0001225208-14-000664:6
- 1,000 shares@ US$9.56Common StockSEC:0001225208-14-000664:7
- 1,300 shares@ US$9.57Common StockSEC:0001225208-14-000664:8
- 1,300 shares@ US$9.54Common StockSEC:0001225208-14-000664:9
- 2,050 shares@ US$9.54Common StockSEC:0001225208-14-000664:10
- 2,300 shares@ US$9.57Common StockSEC:0001225208-14-000664:11
- 3,700 shares@ US$17.89Common StockSEC:0001390974-07-000582:0Canonical exit: 13 Mar 2008 (T+90)
- 1,000 shares@ US$17.96Common StockSEC:0001390974-07-000562:0Canonical exit: 25 Feb 2008 (T+90)
- 600 shares@ US$21.15Common StockSEC:0001390974-07-000506:0Canonical exit: 16 Dec 2007 (T+90)
15 of 15 declarations